Tolerability, pharmacokinetics, and pharmacodynamics of mirogabalin in healthy subjects: Results from phase 1 studies
Author:
Affiliation:
1. Daiichi Sankyo Pharma Development; Basking Ridge New Jersey
2. Daiichi Sankyo Co., Ltd.; Tokyo Japan
Funder
Daiichi-Sankyo
Daiichi Sankyo Company
Publisher
Wiley
Subject
General Pharmacology, Toxicology and Pharmaceutics,Neurology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/prp2.418/fullpdf
Reference16 articles.
1. Pharmacological, pharmacokinetics, and safety profiles of DS-5565, a novel α2δ ligand;Yokoyama;Neurology,2014
2. The Concise Guide to PHARMACOLOGY 2015/16: voltage-gated ion channels;Alexander;Br J Pharmacol,2015
3. The increased trafficking of the calcium channel subunit alpha2delta-1 to presynaptic terminals in neuropathic pain is inhibited by the alpha2delta ligand pregabalin;Bauer;J Neurosci,2009
4. Mechanisms and management of diabetic painful distal symmetrical polyneuropathy;Tesfaye;Diabetes Care,2013
5. Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin;Field;Proc Natl Acad Sci USA,2006
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A phase I study to evaluate the safety, tolerability, and pharmacokinetics of a novel, potent GABA analog HSK16149 in healthy Chinese subjects;Frontiers in Pharmacology;2023-12-11
2. Pharmacokinetics and Bioequivalence of Mirogabalin Orally Disintegrating Tablets and Conventional Tablets in Healthy Japanese Participants;Clinical Pharmacology in Drug Development;2023-06-13
3. The Clinical Application and Progress of Mirogabalin on Neuropathic Pain as a Novel Selective Gabapentinoids;Mediators of Inflammation;2023-04-28
4. Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of Mirogabalin in Healthy Chinese Participants: A Randomized, Double-Blind, Placebo-Controlled Study;Advances in Therapy;2023-02-15
5. Renal tubular transporter-mediated interactions between mirogabalin and cimetidine in rats;Xenobiotica;2023-02-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3